XOMA Co. (NASDAQ:XOMAP – Get Free Report) announced a quarterly dividend on Thursday, June 11th. Investors of record on Thursday, July 2nd will be given a dividend of 0.5391 per share on Tuesday, July 14th. This represents a c) dividend on an annualized basis and a dividend yield of 8.5%. The ex-dividend date of this dividend is Thursday, July 2nd.
XOMA Trading Down 0.0%
Shares of NASDAQ:XOMAP opened at $25.48 on Tuesday. The company’s 50-day moving average price is $25.49 and its 200 day moving average price is $26.02. XOMA has a fifty-two week low of $25.14 and a fifty-two week high of $30.00.
XOMA Company Profile
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Featured Articles
- Five stocks we like better than XOMA
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
